Advertisement
Screener

DAVITA INC. (DVA) Proceeds from Stock Options Exercised

2.8 / 5 stars · 68/120 Roast Me

DAVITA INC. Proceeds from Stock Options Exercised

DAVITA INC. (DVA) reported Proceeds from Stock Options Exercised of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-02-11

  • DAVITA INC. proceeds from stock options exercised for the quarter ending 2018-12-31 was -$8.80M.
  • DAVITA INC. proceeds from stock options exercised for the quarter ending 2018-09-30 was $5.67M, a 25.56% decline year-over-year.
  • DAVITA INC. proceeds from stock options exercised for the quarter ending 2017-12-31 was -$15.78M.
  • DAVITA INC. proceeds from stock options exercised for the quarter ending 2017-09-30 was $7.62M, a 15.82% decline year-over-year.
  • DAVITA INC. proceeds from stock options exercised for fiscal 2025 was $0.00.
  • DAVITA INC. proceeds from stock options exercised for fiscal 2024 was $0.00.
  • DAVITA INC. proceeds from stock options exercised for fiscal 2023 was $0.00.
  • DAVITA INC. proceeds from stock options exercised for fiscal 2022 was $0.00.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 12 monthProceeds from Stock Options Exercised 12 month as first filed
2025-12-31$0.00
10-K · filed 2026-02-11
2024-12-31$0.00
10-K · filed 2026-02-11
2023-12-31$0.00
10-K · filed 2026-02-11
2022-12-31$0.00
10-K · filed 2025-02-13
2021-12-31$0.00
10-K · filed 2024-02-14
2020-12-31$0.00
10-K · filed 2023-02-22
2019-12-31$0.00
10-K · filed 2022-02-11
2018-12-31-$8.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
-$3.13M
derived: sum of 2 quarters · filed 2021-02-12
$0.00
10-K · filed 2021-02-12
2018-09-30$5.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$8.80M
10-Q · filed 2018-11-07
2018-06-30$3.13M
10-Q · filed 2018-08-01
2017-12-31-$15.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
-$8.16M
derived: sum of 2 quarters · filed 2020-02-21
-$3.33M
derived: sum of 3 quarters · filed 2020-02-21
$0.00
10-K · filed 2020-02-21
$21.25M
10-K · filed 2018-02-23
2017-09-30$7.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$12.45M
derived: sum of 2 quarters · filed 2018-11-07
$15.78M
10-Q · filed 2018-11-07
-$2.73M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$4.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$8.16M
10-Q · filed 2018-08-01
-$10.35M
derived: sum of 3 quarters · filed 2019-02-22
-$1.30M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$3.33M
10-Q · filed 2018-05-03
-$15.19M
derived: sum of 2 quarters · filed 2019-02-22
-$6.13M
derived: sum of 3 quarters · filed 2019-02-22
$163.00K
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31-$18.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
-$9.46M
derived: sum of 2 quarters · filed 2019-02-22
-$3.17M
derived: sum of 3 quarters · filed 2019-02-22
$0.00
10-K · filed 2019-02-22
$23.54M
10-K · filed 2017-02-24
2016-09-30$9.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$15.35M
derived: sum of 2 quarters · filed 2017-11-07
$18.52M
10-Q · filed 2017-11-07
$24.87M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$6.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$9.46M
10-Q · filed 2017-08-01
$15.82M
derived: sum of 3 quarters · filed 2018-02-23
$30.94M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$3.17M
10-Q · filed 2017-05-02
$9.52M
derived: sum of 2 quarters · filed 2018-02-23
$24.64M
derived: sum of 3 quarters · filed 2018-02-23
$23.67M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$6.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$21.48M
derived: sum of 2 quarters · filed 2018-02-23
$20.51M
derived: sum of 3 quarters · filed 2018-02-23
$26.16M
10-K · filed 2018-02-23
2015-09-30$15.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$14.15M
derived: sum of 2 quarters · filed 2016-11-02
$19.80M
10-Q · filed 2016-11-02
$24.78M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30-$968.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$4.68M
10-Q · filed 2016-08-08
$9.66M
derived: sum of 3 quarters · filed 2017-02-24
$16.91M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$5.65M
10-Q · filed 2016-05-04
$10.62M
derived: sum of 2 quarters · filed 2017-02-24
$17.87M
derived: sum of 3 quarters · filed 2017-02-24
$21.70M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$4.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$12.23M
derived: sum of 2 quarters · filed 2017-02-24
$16.05M
derived: sum of 3 quarters · filed 2017-02-24
$19.50M
10-K · filed 2017-02-24
2014-09-30$7.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$11.07M
derived: sum of 2 quarters · filed 2015-11-05
$14.52M
10-Q · filed 2015-11-05
$18.52M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$3.82M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-05
$7.27M
10-Q · filed 2015-08-05
$11.27M
derived: sum of 3 quarters · filed 2016-02-26
$14.88M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$3.45M
10-Q/A · filed 2015-05-08
$7.44M
derived: sum of 2 quarters · filed 2016-02-26
$11.05M
derived: sum of 3 quarters · filed 2016-02-26
$14.04M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$3.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$7.60M
derived: sum of 2 quarters · filed 2016-02-26
$10.59M
derived: sum of 3 quarters · filed 2016-02-26
$16.42M
10-K · filed 2016-02-26
2013-09-30$3.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$6.60M
derived: sum of 2 quarters · filed 2014-11-06
$12.43M
10-Q · filed 2014-11-06
$10.68M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30$2.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$8.82M
10-Q · filed 2014-08-01
$7.07M
derived: sum of 3 quarters · filed 2015-02-26
$10.62M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31$5.83M
10-Q · filed 2014-05-02
$4.08M
derived: sum of 2 quarters · filed 2015-02-26
$7.63M
derived: sum of 3 quarters · filed 2015-02-26
$10.82M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31-$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
$1.80M
derived: sum of 2 quarters · filed 2015-02-26
$4.98M
derived: sum of 3 quarters · filed 2015-02-26
$6.65M
10-K · filed 2015-02-26
2012-09-30$3.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$6.73M
derived: sum of 2 quarters · filed 2013-11-06
$8.39M
10-Q · filed 2013-11-06
$9.82M
derived: sum of 4 quarters · filed 2014-02-21
2012-06-30$3.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
$4.84M
10-Q · filed 2013-08-07
$6.28M
derived: sum of 3 quarters · filed 2014-02-21
$8.75M
derived: sum of 4 quarters · filed 2014-02-21
2012-03-31$1.66M
10-Q · filed 2013-05-09
$3.09M
derived: sum of 2 quarters · filed 2014-02-21
$5.57M
derived: sum of 3 quarters · filed 2014-02-21
$9.57M
derived: sum of 4 quarters · filed 2014-02-21
2011-12-31$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
$3.91M
derived: sum of 2 quarters · filed 2014-02-21
$7.91M
derived: sum of 3 quarters · filed 2014-02-21
$11.32M
10-K · filed 2014-02-21
2011-09-30$2.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31
$6.48M
derived: sum of 2 quarters · filed 2012-10-31
$9.89M
10-Q · filed 2012-10-31
$24.23M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$7.41M
10-Q · filed 2012-08-03
$21.75M
derived: sum of 3 quarters · filed 2013-03-01
$27.06M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31$3.41M
10-Q · filed 2012-05-02
$17.75M
derived: sum of 2 quarters · filed 2013-03-01
$23.06M
derived: sum of 3 quarters · filed 2013-03-01
$36.10M
derived: sum of 4 quarters · filed 2013-03-01
2010-12-31$14.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
$19.65M
derived: sum of 2 quarters · filed 2013-03-01
$32.69M
derived: sum of 3 quarters · filed 2013-03-01
$53.76M
10-K · filed 2013-03-01
2010-09-30$5.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$18.34M
derived: sum of 2 quarters · filed 2011-11-04
$39.42M
10-Q · filed 2011-11-04
$77.02M
derived: sum of 4 quarters · filed 2012-07-06
2010-06-30$13.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04
$34.11M
10-Q · filed 2011-08-04
$71.71M
derived: sum of 3 quarters · filed 2012-07-06
$85.33M
derived: sum of 4 quarters · filed 2012-07-06
2010-03-31$21.07M
10-Q · filed 2011-05-06
$58.67M
derived: sum of 2 quarters · filed 2012-07-06
$72.29M
derived: sum of 3 quarters · filed 2012-07-06
$79.88M
derived: sum of 4 quarters · filed 2012-07-06
2009-12-31$37.60M
derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06
$51.22M
derived: sum of 2 quarters · filed 2012-07-06
$58.81M
derived: sum of 3 quarters · filed 2012-07-06
$67.91M
8-K · filed 2012-07-06
2009-09-30$13.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$21.21M
derived: sum of 2 quarters · filed 2010-11-05
$30.31M
10-Q · filed 2010-11-05
$36.89M
derived: sum of 4 quarters · filed 2011-02-25
2009-06-30$7.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05
$16.69M
10-Q · filed 2010-08-05
$23.27M
derived: sum of 3 quarters · filed 2011-02-25
$44.17M
derived: sum of 4 quarters · filed 2011-02-25
2009-03-31$9.10M
10-Q · filed 2010-05-03
$15.68M
derived: sum of 2 quarters · filed 2011-02-25
$36.58M
derived: sum of 3 quarters · filed 2011-02-25
2008-12-31$6.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25
$27.48M
derived: sum of 2 quarters · filed 2011-02-25
$40.25M
10-K · filed 2011-02-25
2008-09-30$20.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05
$33.67M
10-Q · filed 2009-11-05
2008-06-30$12.77M
10-Q · filed 2009-08-07
2007-12-31$62.90M
10-K · filed 2010-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43